Autonomic dysfunction and anemia in neurologic disorders

Journal of the Autonomic Nervous System

Volumn 61, Issue 2, 1996, Pages 145-148

  Ando, Yukio ^a,b   Asahara, Keiko ^a   Obayashi, Konen ^a   Suhr, Ole ^b   Yonemitsu, Mizue ^a   Yamashita, Taro ^a   Tashima, Kazuhiro ^a   Uchino, Makoto ^a   Ando, Masayuki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Anemia; Familial amyloidotic polyneuropathy; Human recombinant erythropoietin; Orthostatic hypotension; Pandysautonomia; Shy Drager syndrome

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; AMYLOID NEUROPATHY; ANEMIA; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

ADULT; AGED; AMYLOID NEUROPATHIES; AMYOTROPHIC LATERAL SCLEROSIS; ANEMIA; BIOPSY, NEEDLE; BONE MARROW; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYNEUROPATHIES; SHY-DRAGER SYNDROME;

EID: 0030572886     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(96)00070-7     Document Type: Article

References (21)

1. [1] Ando, Y., Yi, S., Nakagawa, T., Ikegawa, S., Hirota, M., Miyazaki, A. and Araki, S., Disturbed metabolism of glucose and related hormones in familial amyloidotic polyneuropathy: Hypersensitivities of the autonomic nervous system and therapeutic prevention, J. Auton. Nerv. Syst., 35 (1991) 63-70.
2. [2] Ando, Y., Araki, S. and Ando, M., Transthyretin related amyloidosis, Intern. Med., 32 (1993) 920-922.
3. [3] Araki, S., Type I familial amyloidotic polyneuropathy (Japanese type), Brain. Dev., 6 (1984) 128-133.
4. [4] Araki, S., Ikegawa, S., Yi, S., Murakami, T., Nishiguchi, S., Ando, Y. and Miyazaki A., Atypical cases of familial amyloidotic polyneuropathy (FAP) in Japan. In P. Costa (Ed.), Familial Amyloidotic Polyneuropathy and other Transthyretin Related Disorders. Arquivos de Medica, Port, 1990, pp. 255-259.
5. [5] Asahara, K., Ando, Y., Tanaka, Y., Yi, S., Yamashita, T. and Ando, M., Secondary hypoplastic anemia in patients with familial amyloidotic polyneuropathy, Acta Haematol., 90 (1993) 130-135.
6. [6] Beynon, G., The influence of autonomic nervous system in the control of erythropoietin secretion in the hypoxic rat, J. Physiol., 266 (1977) 347-360.
7. [7] Biaggioni, I., Garcia, F., Inagami, T. and Haile, V., Hyporemic normoaldesteronism in severe autonomic failure, J. Clin. Endocrinol. Metab., 76 (1993) 580-586.
8. [8] Biaggioni, I., Robertson, D., Krantz, S., Jones, M. and Haile, V., The anemia of primary autonomic failure and its reversal with recombinant erythropoietin, Ann. Intern. Med. 121 (1994) 181-186.
9. [9] Bulloch, K., Neuroanatomy of lymphoid tissue. In R. Guillemin (Ed), Neural Modulation of Immunity. Raven Press, New York, 1985, pp. 111-141.
10. [10] Fink, G.D., Paulo, L.G. and Fisher, J.W., Effect of beta adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia, J. Pharmacol. Exp. Ther., 193 (1975) 176-181.
11. [11] Fink, G.D. and Fisher, J.W., Stimulation of erythropoiesis by beta adrenergic agonist. II. Mechanism of action, J. Pharmacol. Exp. Ther., 202 (1977) 199-208.
12. [12] Garn, S.M., Ryan, A.S., Abraham, S. and Owen, G., Suggested sex and age appropriate values for 'low' and 'deficient' hemoglobin levels, Am. J. Clin. Nutr., 34 (1981) 1651-1658.
13. [13] Goodnough, L.T., Rudnick, S., Price, T.H., Ballas, S.K., Gollins, M.L., Crowley, J.P., Kosmin, M., Kruskall, M.S., Lenes, B.A. and Menitrous, J.E., Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy, New Engl. J. Med., 321 (1989) 1163-1168.
14. [14] Hoeldtke, R. and Streeten, D., Treatment of orthostatic hypotension with erythropoietin. New Engl. J. Med., 329 (1993) 611-615.
15. [15] Jandeleit, K., Heintz, B., Gross-Heitfeld, E., Kindler, J., Sieberth, H.G., Kirsten, R. and Nelson, K., Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietin (letter), Nephron, 56 (1990) 220-221.
16. [16] Ludwig, H. and Fritz, E., Erythropoietin treatment of anemia associated with human myeloma, New Engl. J. Med., 322 (1990) 1693-1699.
17. [17] Olofsson, B.O., Grankvist, K. and Boman, K., Evaluation of the anaemia in familial amyloidotic polyneuropathy, Eur. J. Intern. Med., 1 (1990) 425-429.
18. [18] Shy, G.M. and Drager, G.A., A neurological syndrome associated with orthostatic hypotension, Arch. Neurol., 2 (1960) 511-527.
19. [19] Takaku, F., Hirashima, K. and Okinaka, S., Effect of bilateral section of the splanchnic nerve on erythropoiesis, Nature, 191 (1961) 500-501.
20. [20] Wintrobe, M.M., Richard, G.L. and Boggs, D.R. In M.M. Wintrobe, G.L. Richard and D.R. Boggs (Eds), Medullary Hematopoiesis, Clinical Hematology, 8th Ed. Lea and Hebiger. Philadelphia, 1981, pp. 52-61.
21. [21] Zivny, J., Ostadal, B., Neuwirt, J., Prochazka, J. and Pelouch, V., Effect of beta adrenergic blocking agents on erythropoiesis in rats, J. Pharmacol. Exp. Ther., 226 (1983) 222-225.